MedTrace Logo

Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer

NCT00689364 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2011-07-22

No results posted yet for this study

Summary

Comprehensive therapy of traditional Chinese medicine (CTTCM) could relieve risk of recurrence and metastasis for stage II \& III colorectal cancer, the investigators take this clinical trial with retrospective-prospective cohort study based on previous studies by international multi-center way.

If the study shows a positive result, a pragmatic randomized controlled study with prospective, multi-centre and large-sample design will be given continuously. The aim is to establish recommended programs suggested by CTTCM strategies under conventional Western medicine therapy (CWMT) for stage II \& III colorectal cancer.

Conditions

Sponsors & Collaborators

  • National Research Centre of Complementary and Alternative Medicine, Norway

    collaborator OTHER

  • Ministry of Science and Technology of the People´s Republic of China

    lead OTHER_GOV

Principal Investigators

  • Yang Yufei, doctor · Xi-Yuan Hospital, China Academy of Chinese Medical Sciences, China

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2012-03-31
Completion
2014-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00689364 on ClinicalTrials.gov